Murphy Andrew J's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Feb 16, 2022
- Accession no.
- 0001708138-22-000014
- Filed
- Feb 16, 2022
- Trade date
- Feb 14-15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 13 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.23M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Murphy Andrew JCIK 0001796226 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $179.13 | +$1,791,300 | 68,470 | Direct | |
| Feb 14, 2022 | Common Stock | FTax withholdingDisposed | −6,460 | $626.79 | −$4,049,063.4 | 62,010 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −99 | $622.09F2 | −$61,586.91 | 61,911 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −50 | $625.90 | −$31,295 | 61,861 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −421 | $626.51F3 | −$263,760.71 | 61,440 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −630 | $627.49F4 | −$395,318.7 | 60,810 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −520 | $628.62F5 | −$326,882.4 | 60,290 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −533 | $629.35F6 | −$335,443.55 | 59,757 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −434 | $630.41F7 | −$273,597.94 | 59,323 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −185 | $631.67F8 | −$116,858.95 | 59,138 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −289 | $632.71F9 | −$182,853.19 | 58,849 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −220 | $633.54F10 | −$139,378.8 | 58,629 | Direct | |
| Feb 15, 2022 | Common Stock | SSaleDisposed | −159 | $634.43F11 | −$100,874.37 | 58,470 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 30,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 99 shares of Company stock on February 15, 2022 at prices ranging from $622.00 to $622.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 421 shares of Company stock on February 15, 2022 at prices ranging from $626.08 to $626.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 630 shares of Company stock on February 15, 2022 at prices ranging from $627.00 to $627.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 520 shares of Company stock on February 15, 2022 at prices ranging from $628.09 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 533 shares of Company stock on February 15, 2022 at prices ranging from $629.00 to $629.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 434 shares of Company stock on February 15, 2022 at prices ranging from $630.18 to $630.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 185 shares of Company stock on February 15, 2022 at prices ranging from $631.29 to $631.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 289 shares of Company stock on February 15, 2022 at prices ranging from $632.28 to $632.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 220 shares of Company stock on February 15, 2022 at prices ranging from $633.26 to $633.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 159 shares of Company stock on February 15, 2022 at prices ranging from $634.23 to $634.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 15, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.